Mo Yang, Hua Chen, Michael L. Johnson, E. Essien, R. Peters, X. Wang, S. Abughosh
{"title":"肥胖吸烟者戒烟药物戒断率的比较","authors":"Mo Yang, Hua Chen, Michael L. Johnson, E. Essien, R. Peters, X. Wang, S. Abughosh","doi":"10.5455/JBH.20160414103729","DOIUrl":null,"url":null,"abstract":"Although both varenicline and bupropion have been reported to be effective in terms of increasing the abstinence rate, while previous literature among adults reports better abstinence with varenicline compared to bupropion, our findings among obese smokers indicate no difference in abstinence for those using bupropion compared to those using varenicline.","PeriodicalId":90204,"journal":{"name":"Journal of behavioral health","volume":"5 1","pages":"95-104"},"PeriodicalIF":0.0000,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Comparison of Abstinence Rates of Smoking Cessation Medications among Obese Smokers\",\"authors\":\"Mo Yang, Hua Chen, Michael L. Johnson, E. Essien, R. Peters, X. Wang, S. Abughosh\",\"doi\":\"10.5455/JBH.20160414103729\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Although both varenicline and bupropion have been reported to be effective in terms of increasing the abstinence rate, while previous literature among adults reports better abstinence with varenicline compared to bupropion, our findings among obese smokers indicate no difference in abstinence for those using bupropion compared to those using varenicline.\",\"PeriodicalId\":90204,\"journal\":{\"name\":\"Journal of behavioral health\",\"volume\":\"5 1\",\"pages\":\"95-104\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of behavioral health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5455/JBH.20160414103729\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of behavioral health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5455/JBH.20160414103729","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Comparison of Abstinence Rates of Smoking Cessation Medications among Obese Smokers
Although both varenicline and bupropion have been reported to be effective in terms of increasing the abstinence rate, while previous literature among adults reports better abstinence with varenicline compared to bupropion, our findings among obese smokers indicate no difference in abstinence for those using bupropion compared to those using varenicline.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
